Trial intelligence / Profile preview

TEMACA: Acamprosate and Calcium in Alcohol Dependence

NCT03634917Phase 3Completed

Sponsor
Technische Universität Dresden
Start
Aug 2020
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of calcium carbonate in alcohol use disorder (AUD) (3 arms), sponsored by Technische Universität Dresden. Primary endpoint: Difference between cumulative CAT trials for alcohol on 1st and 2nd ASA day. Started Aug 2020; status: completed.

02

Drugs

calcium carbonate
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT03634917.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03634917.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call